Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Liver Disease Treatment Market Expected to Generate a Revenue of $32,028.5 Million by 2028, Growing at a CAGR of 11.7% from 2021-2028 - Exclusive Report [240 Pages] By Research Dive

This image opens in the lightbox

News provided by

Research Dive

30 Sep, 2021, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

NEW YORK, Sept. 30, 2021 /PRNewswire/ -- The global liver disease treatment market is expected to witness a noteworthy growth by 2028, owing to the government initiatives. The Asia-Pacific region is expected to dominate in the global market in the projected timeframe.

According to the report added by Research Dive to its offerings, the Global Liver Disease Treatment Market is expected to generate a revenue of $32,028.5 million by 2028, growing expeditiously at a CAGR of 11.7% during the forecast period.

Dynamics of the Market

Increasing prevalence of non-alcoholic fatty liver disease (NAFLD) leading to chronic liver disorder among people in developing countries is expected to drive the growth of the liver disease treatment market during the forecast period. In addition, increasing consumption of alcohol among people and numerous initiatives taken by the governments by organizing various awareness programs on liver diseases are further expected to bolster the growth of the market by 2028. But, high cost of investment in the development of liver disease treatment drugs is expected to impede the growth of the market in the coming future. However, extensive prevalence of liver diseases, especially in Middle East and Latin American countries are expected to create massive opportunities for the growth of the global market during the forecast period.

Download PDF Sample Report of Liver Disease Treatment Market

Impact of COVID-19 on the Liver Disease Treatment Market

The outbreak of coronavirus has had a negative impact on the global liver disease treatment market, owing to the prevalence of lockdowns in various countries across the globe. During the pandemic more and more researchers were inclined towards the trials on COVID-19-related medications, and hence the liver disease research projects were delayed. In addition, disruption in the supply chain and import-export restrictions imposed by the government further decreased the demand for liver disease treatment medicines.

Get Access to Comprehensive Analysis of the Impact of Covid-19 on Liver Disease Treatment Market

Segments of the Market

The report has divided the market into various segments based on treatment type, disease type, end-user, and region.

  • By treatment type, the antiviral drugs sub-segment is expected to be most profitable, and generate a revenue of $13,503.3 million during the forecast period. Increasing healthcare expenditure and surging prevalence of hepatitis B and C among people are expected to drive the growth of the sub-segment during the forecast period.
  • By disease type, the hepatitis sub-segment is expected to be most beneficial, and generate a revenue of $21,729.3 million during the forecast period. Increasing prevalence of inflammation condition of liver tissue due to excessive alcohol consumption, viral infection, nonalcoholic steatohepatitis, and many more are consequently predicted to bolster the growth of the sub-segment in the analysis period.
  • By end-user, the hospitals sub-segment is expected to be most lucrative, and generate a revenue of $22,276.3 million during the forecast period. Growing need for advanced healthcare facilities along with integrated liver treatment hospitals is expected to drive the growth of the sub-segment in the analysis period.
  • By region, the Asia-Pacific region is expected to dominate the market, and generate a revenue of $4,099.7 million during the forecast period. Prevalence of innovative liver disease therapeutics along with the growing cases of NAFLD and hepatitis in this region are expected to accelerate the growth of the liver disease treatment market during the forecast period.

Competitive intelligence on Organic Dinnerware Market players in the Asia Pacific region - Get Special Discount of 20% available on a *first-come-first-served basis

Top 10 Key Players of the Liver Disease Treatment Market

The major players of the market include –

  1. Pfizer Inc.
  2. Johnson & Johnson Services, Inc.
  3. F. Hoffmann-La Roche Ltd
  4. GlaxoSmithKline plc.
  5. Sanofi
  6. Novartis AG
  7. Bayer AG
  8. Bristol Myers Squibb (BMS)
  9. Gilead Sciences, Inc.
  10. AbbVie

Inquire and Get Quick Access to Top Companies Development Strategies Summary Report

These players are working on developing strategies such as product development, merger and acquisition, partnerships and collaborations to sustain the market growth.

For instance, in August 2021, Sanofi, a French Multinational Pharmaceutical Company, is set to acquire Translate Bio, clinical-stage mRNA Therapeutics Company, in order to facilitate the development of top-class vaccines and therapeutics and maximize research potential to explore other therapeutic areas.

The report also summarizes many important aspects including financial performance of the key players, SWOT analysis, product portfolio, and latest strategic developments.

More about Liver Disease Treatment Market:

  • The Rising Prevalence of Obesity Worldwide to Drive the Global Liver Disease Treatment Market
  • Collaborations like that of HemoShear Therapeutics, LLC with Takeda Pharmaceuticals to Offer the Global Liver Disease Treatment Market with Ample Opportunities
  • A Happy and Healthy Life Sustains with a Healthy Liver

Related Trending Topics:

  1. Antibiotics Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 – Request to Download Sample Report
  2. Human Papillomavirus Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 – Request to Download Sample Report

    About Research Dive

    Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

    Contact:

    Mr. Abhishek Paliwal
    Research Dive
    30 Wall St. 8th Floor, New York NY 10005
    (P) +91-(788)-802-9103 (India)
    Toll Free: 1-888-961-4454
    E-mail: support@researchdive.com
    Website: https://www.researchdive.com
    Blog: https://www.researchdive.com/blog/  
    LinkedIn: https://www.linkedin.com/company/research-dive/
    Twitter: https://twitter.com/ResearchDive
    Facebook: https://www.facebook.com/Research-Dive-1385542314927521

    Logo : https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg

    Modal title

    Contact PR Newswire

    • +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
    • General Enquiries
    • Media Enquiries
    • Partnerships

    Products

    • Content Distribution
    • Multimedia Services
    • Disclosure Services
    • Cision Communications Cloud®

    About

    • About PR Newswire
    • About Cision
    • Partnering Opportunities
    • Careers
    • Accessibility Statement
    • APAC
    • APAC - Simplified Chinese
    • APAC - Traditional Chinese
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Indonesia
    • Israel
    • Japan
    • Korea
    • Mexico
    • Middle East
    • Middle East - Arabic
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United States
    • Vietnam

    My Services

    • All News Releases
    • Customer Portal
    • Resources
    • Blog
    • Journalists
    • Data Privacy

    Do not sell or share my personal information:

    • Submit via Privacy@cision.com 
    • Call Privacy toll-free: 877-297-8921

    Contact PR Newswire

    Products

    About

    My Services
    • All News Releases
    • Customer Portal
    • Resources
    • Blog
    • Journalists
    +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
    • Terms of Use
    • Privacy Policy
    • Information Security Policy
    • Site Map
    • RSS
    • Cookie Settings
    Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.